Close Menu

The Scan

A blogger rounds up CSHL's Genome Informatics meeting.

Researchers link genetics with the Viking history of surnames in Britain.

Swiss scientists are using a high-powered computer to build a remarkably detailed, simulated brain.

GMO gets a boost in Britain, but sees trouble in Germany and the US.

As stem cell scientists work to make recent advances available to a broad community, an unlikely source takes credit.

Elsevier launches 2collab, a social bookmarking website.

Eli Lilly's CEO pens an op-ed piece in an attempt to explain what went wrong with a promising new drug. (Spoiler alert: it's the media.)

More open-access journals warm Bora Zivkovic's heart.

Make use of the Internet to find your perfect science job, says a blogger.

BioMed Central launches a YouTube channel.

Blogger David Ng posts a picture that will make you laugh.

DNA testing, specifically for ancestry purposes, has not shown impressive reliability.

An op-ed in the Times sparks debate over whether there's room for faith in science.

A blogger faces the fear that his results might not be correct if there's something wrong with the underlying code.

Science has Sydney Brenner, cell signaling, and DNA duplexes.

From VentureBeat, an article on an alternative revenue source for 23andMe: pharmas interested in mining their data.

Nature has papers on termite metagenomics and primate cloning, as well as news on Germany's first national academy of science.

FASEB is asking scientists to support their YouTube videos to make sure that research-related questions are chosen as part of a US presidential debate.

A blogger says the fear of appearing racist may stifle good science into genetic differences based on people's ethnic and geographic background.

A blogger comments on Gene Logic and drug repositioning.

Steven Salzberg posts on news that scientists have been able to create human embryonic stem cells from skin cells.

Scientists are using genetic technology to produce trees that could be better sources of biofuel.

Sandra Porter has a much-needed post on quality scores in DNA sequencing as her response to the onslaught of personal genomics companies.

John Tierney at the New York Times says that a group's reaction to concepts such as human cloning are largely linked to religious views.

Biotech firm Celgene acquires Pharmion for $2.9 billion.


Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.